AK
Aditya Kumar Jain
About Aditya Kumar Jain
Data last updated:
Aditya Kumar Jain has 3 years in corporate governance. Holds Director role. Currently with 2 companies, including Unihenz Pharmaceutical Private Limited and Gsharn Pharmaceuticals Private Limited. Engaged in General Business. Contributes to corporate operations. The largest current company by reported revenue is Gsharn Pharmaceuticals Private Limited at ₹25.7 Lakh (FY 2024).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 08 Jun 2023 | 2021 | ₹25.7 Lakh (FY 2024) | Active | |
| Director | 03 Mar 2024 | 2024 | – | Active |
Previous companies
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Aditya Kumar Jain
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Aditya Kumar Jain
Aditya Kumar Jain has 3 years in corporate governance. Holds Director role. Currently with 2 companies, including Unihenz Pharmaceutical Private Limited and Gsharn Pharmaceuticals Private Limited. Engaged in General Business. Contributes to corporate operations. The largest current company by reported revenue is Gsharn Pharmaceuticals Private Limited at ₹25.7 Lakh (FY 2024).
Aditya Kumar Jain is associated with 2 companies as Director, including Gsharn Pharmaceuticals Private Limited (₹25.7 Lakh), Unihenz Pharmaceutical Private Limited.
Aditya Kumar Jain has expertise in General Business.
Aditya Kumar Jain has 3 years in corporate governance.
By reported revenue, the largest current company of Aditya Kumar Jain is Gsharn Pharmaceuticals Private Limited, with revenue of ₹25.7 Lakh (FY 2024).
Aditya Kumar Jain currently holds positions at 2 companies: Gsharn Pharmaceuticals Private Limited (₹25.7 Lakh), Unihenz Pharmaceutical Private Limited.